BRKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bruker Corp (BRKR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance in the latest quarter is weak, and analyst sentiment is mixed to negative with multiple price target downgrades. While there is no strong indication of a near-term recovery, the stock may be worth monitoring for future opportunities.
The technical indicators for BRKR are bearish. The stock's moving averages (SMA_200 > SMA_20 > SMA_5) suggest a downward trend. RSI is neutral at 34.897, and the MACD histogram is positive but contracting. Key support is at 38.02, with resistance at 41.014. The stock is trading near its support level, but no clear reversal signal is present.
No significant positive catalysts identified. UBS and BofA maintain a Neutral and Buy rating, respectively, with price targets of $49, which is above the current price.
Disappointing Q4 earnings, weak margins, and free cash flow. Analysts have lowered price targets significantly, citing a steep ramp needed to meet 2026 guidance. Options data shows bearish sentiment. Hedge funds and insiders are neutral, with no significant trading trends.
In Q4 2025, revenue dropped by -0.24% YoY to $977.2M. Net income and EPS fell to 0, down -100% YoY. Gross margin decreased by -8.92% YoY to 46.03%. The financial performance indicates significant challenges.
Analyst sentiment is mixed to negative. Multiple firms, including Citi, TD Cowen, and Goldman Sachs, have lowered price targets, citing weak Q4 results and challenging guidance. However, some firms like BofA and Jefferies maintain Buy ratings with reduced targets, indicating cautious optimism for the long term.
